Dermata Therapeutics, Inc.
Dermata Therapeutics, Inc. engages in the development and distribution of over-the-counter pharmaceutical dermatology-focused products in the United States. The company develops direct-to-consumer skincare products, including foundation treatment products for skin renewal and clearing treatment products for the treatment of acne under the Tome brand. Dermata Therapeutics, Inc. was incorporated in 2014 and is headquartered in San Diego, California.
| Period | EPS | Revenue | FCF |
|---|---|---|---|
| 2026 Q3 | -0.55 | $74,137 | -$3M |
| 2026 Q2 | -0.74 | $0 | -$3M |
| 2026 Q1 | -0.48 | $0 | -$2M |
| 2025 Q4 | -1.52 | $0 | -$1M |
| 2025 Q3 | -1.65 | $0 | -$2M |
| 2025 Q2 | -1.66 | $0 | -$3M |
| 2025 Q1 |
| -4.47 |
| $0 |
| -$2M |
| 2024 Q4 | -20.40 | $0 | -$3M |